Daiichi Sankyo has been listed on the 2020 DJSI World for the fourth consecutive year and DJSI Asia Pacific for the eleventh consecutive year.

The Company was recognized for its strong performance in the areas of Marketing Practice, Environmental Reporting, Environmental Policy & Management System and Social Reporting.

Daiichi Sankyo will continue to make every effort to realize our corporate mission, "To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs," while fulfilling our social responsibility by performing activities that appropriately respond to sustainability challenges as we aim to continuously enhance corporate value.